Tumor necrosis factor α induces a caspase-independent death pathway in human neutrophils

Blood

Volumn 101, Issue 5, 2003, Pages 1987-1995

  Malanski, Nikolai A ^b   Roos, Dirk ^b   Kuijpers, Taco W ^a  

^a CENTRAL LABORATORY   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CASPASE; CASPASE 3; CASPASE 8; CASPASE INHIBITOR; CYTOKINE; FAS ANTIGEN; PHOSPHATIDYLSERINE; PROTEIN BAX; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SCAVENGER; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CASE REPORT; CELL FUNCTION; CELL MEMBRANE; CELL NUCLEUS; CELL STRUCTURE; CELL SURVIVAL; CHROMATIN CONDENSATION; CHRONIC GRANULOMATOUS DISEASE; CONTROLLED STUDY; CYTOPLASM; DNA STRAND BREAKAGE; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; IMMUNE SYSTEM; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; NEUTROPHIL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION;

EID: 0037370784     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-02-0522     Document Type: Article

References (73)

1. Tracey KJ, Cerami A. Tumor necrosis factor, other cytokines and disease. Annu Rev Cell Biol. 1993;9:317-343.
2. Feldmann M, Brennan FM, Maini RN. Rheumatold arthritis. Cell. 1996;85:307-310.
3. Parsons PE, Moore FA, Moore EE, Ikle DN, Henson PM, Worthen GS. Studies on the role of tumor necrosis factor in adult respiratory distress syndrome. Am Rev Respir Dis. 1992;146:694-700.
4. Windsor AC, Walsh CJ, Mullen PG, et al. Tumor necrosis factor-alpha blockade prevents neutrophil CD18 receptor upregulation and attenuates acute lung injury in porcine sepsis without inhibition of neutrophil oxygen radical generation. J Clin Invest. 1993;91:1459-1468.
5. Marino MW, Dunn A, Grail D, et al. Characterization of tumor necrosis factor-deficient mice. Proc Natl Acad Sci U S A. 1997;94:8093-8098.
6. Liu J, Marino MW, Wong G, et al. TNF is a potent anti-inflammatory cytokine in autolmmune-mediated demyelination. Nat Med. 1998;4:78-83.
7. Savill JS, Wyllie AH, Henson JE, Walport MJ, Henson PM, Haslett C. Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages. J Clin Invest. 1989;83:865-875.
8. Savill J, Fadok V. Corpse clearance defines the meaning of cell death. Nature. 2000;407:784-788.
9. Takeda Y, Watanabe H, Yonehara S, Yamashita T, Saito S, Sendo F. Rapid acceleration of neutrophil apoptosis by tumor necrosis factor-alpha. Int Immunol. 1993;5:691-694.
10. Watson RW, Redmond HP, Wang JH, Bouchier-Hayes D. Bacterial ingestion, tumor necrosis factor-alpha, and heat induce programmed cell death in activated neutrophils. Shock. 1996;5:47-51.
11. Murray J, Barbara JA, Dunkley SA, et al. Regulation of neutrophil apoptosis by tumor necrosis factor-alpha: requirement for TNFR55 and TNFR75 for induction of apoptosis in vitro, Blood. 1997;90:2772-2783.
12. Kettritz R, Gaido ML, Hailer H, Luft FC, Jennette CJ, Falk RJ. Interleukin-8 delays spontaneous and tumor necrosis factor-alpha-mediated apoptosis of human neutrophils. Kidney Int. 1998;53:84-91.
13. Yamashita K, Takahashi A, Kobayashi S, et al. Caspases mediate tumor necrosis factor-alpha-induced neutrophil apoptosis and downregulation of reactive oxygen production. Blood. 1999;93:674-685.
14. Weinmann P, Gaehtgens P, Walzog B. Bcl-XL-and Bax-α-mediated regulation of apoptosis of human neutrophils via caspase-3. Blood. 1999;99:3106-3115.
15. Colotta F, Re F, Polentarutti N, Sozzani S, Mantovani A. Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood. 1992;80:2012-2020.
16. Keel M, Ungethum U, Steckholzer U, et al. Interleukin-10 counterregulates proinflammatory cytokine-induced inhibition of neutrophil apoptosis during severe sepsis. Blood. 1997;90:3356-3363.
17. van den Berg JM, Weyer S, Weening JJ, Roos D, Kuijpers TW. Divergent effects of tumor necrosis factor-alpha on apoptosis of human neutrophils. J Leukoc Biol. 2001;69:467-473.
18. Reed JC. Mechanisms of apoptosis. Am J Pathol. 2000;157:1415-1430.
19. Hengartner MO. The biochemistry of apoptosis. Nature. 2000;407:770-776.
20. Kischkel FC, Hellbardt S, Behrmann I, et al. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J. 1995;14:5579-5588.
21. Ashkenazi A, Dixit VM. Death receptors: signaling and modulation. Science. 1998;281:1305-1308.
22. Garcia-Calvo M, Peterson EP, Leiting B, Ruel R, Nicholson DW, Thornberry NA. Inhibition of human caspases by peptide-based and macromolecular inhibitors. J Biol Chem. 1998;273:32608-32613.
23. Fadeel B, Ahlin A, Ftenter JI, Orrenius S, Hampton MB. Involvement of caspases in neutrophil apoptosis: regulation by reactive oxygen species. Blood. 1998;92:4808-4818.
24. Maianski NA, Mul FPJ, van Buul JD, Roos D, Kuijpers TW. Granulocyte colony-stimulating factor inhibits the mitochondria-dependent activation of caspase-3 in neutrophils. Blood. 2002;99:672-679.
25. Roos D, de Boer M. Purification and cryopreservation of phagocytes from human blood. Methods Enzymol. 1986;132:225-243.
26. Roos D, Voetman AA. Preparation and cryopreservation of cytoplasts from human phagocytes. Methods Enzymol. 1986;132:250-257.
27. Muzio M, Chinnaiyan AM, Kischkel FC, et al. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell. 1996;85:817-827.
28. Scaffidi, C, Fulda S, Srinivasan A, et al. Two CD95 (APO-1 /Fas) signaling pathways. EM BO J. 1998;17:1675-1687.
29. Moulding DA, Quayle JA, Hart CA, Edwards SW. Mcl-1 expression in human neutrophils: regulation by cytokines and correlation with cell survival. Blood. 1998;92:2495-2502.
30. Moulding DA, Akgul C, Derouet M, White MR, Edwards SW. BCL-2 family expression in human neutrophils during delayed and accelerated apoptosis. J Leukoc Biol. 2001;70:783-792.
31. Epling-Burnette PK, Zhong B, Bai F, et al. Cooperative regulation of Mcl-1 by Janus kinase/stat and phosphatidylinositol 3-kinase contribute to granulocyte-macrophage colony-stimulating factor-delayed apoptosis in human neutrophils. J Immunol. 2001;166:7486-7495.
32. Wyllie AH. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature. 1980;284:555-556.
33. Nagata S, Golstein P. The Fas death factor. Science. 1995;267:1449-1456.
34. Kasahara Y, Iwai K, Yachie A, et al. Involvement of reactive oxygen intermediates in spontaneous and CD95 (Fas/APO-1)-mediated apoptosis of neutrophils. Blood. 1997;89:1748-1753.
35. Wolter KG, Hsu YT, Smith CL, Nechushtan A, Xi XG, Youle RJ. Movement of Bax from the cytosol to mitochondria during apoptosis. J Cell Biol. 1997;139:1281-1292.
36. Goping IS, Gross A, Lavoie JN, et al. Regulated targeting of BAX to mitochondria. J Cell Biol. 1998;143:207-215.
37. Khaled AR, Kim K, Hofmeister R, Muegge K, Durum SK. Withdrawal of IL-7 induces Bax translocation from cytosol to mitochondria through a rise in intracellular pH. Proc Natl Acad Sci U S A. 1999;96:14476-14481.
38. Murphy KM, Ranganathan V, Farnsworth ML, Kavallaris M, Lock RB. Bcl-2 inhibits Bax translocation from cytosol to mitochondria during drug-induced apoptosis of human tumor cells. Cell Death Differ. 2000;7:102-111.
39. Roos D, Voetman AA, Meerhof LJ. Functional activity of enucleated human polymorphonuclear leukocytes. J Cell Biol. 1983;97:368-377.
40. Suzuki K, Hino M, Hato F,Tatsumi N, Kitagawa S. Cytokine-specific activation of distinct mitogen-activated protein kinase subtype cascades in human neutrophils stimulated by granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, and tumor necrosis factor-alpha. Blood. 1999;93:341-349.
41. Schulze-Osthoff K, Bakker AC, Vanhaesebroeck B, Beyaert R, Jacob WA, Fiers W. Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation. J Biol Chem. 1992;267:5317-5323.
42. Goossens V, Grooten J, De Vos K, Fiers W. Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity. Proc Natl Acad Sci U S A. 1995;92:8115-8119.
43. Moreno-Manzano V, Ishikawa Y, Lucio-Cazana J, Kitamura M. Selective involvement of superoxide anion, but not downstream compounds hydrogen peroxide and peroxynitrite, in tumor necrosis factor-alpha-induced apoptosis of rat mesangial cells. J Biol Chem. 2000;275:12684-12691.
44. Khwaja A, Tatton L. Resistance to the cytotoxic effects of tumor necrosis factor alpha can be overcome by inhibition of a FADD/caspase-dependent signaling pathway. J Biol Chem. 1999;274:36817-36823.
45. Pani G, Colavitti R, Borrello S, Galeotti T. Endogenous oxygen radicals modulate protein tyrosine phosphorylation and JNK-1 activation in lectin-stimulated thymocytes. Biochem J. 2000;347:173-181.
46. Peachman KK, Lyles DS, Bass DA. Mitochondria in eosinophils: functional role in apoptosis but not respiration. Proc Natl Acad Sci U S A. 2001;98:1717-1722.
47. Borregaard N, Herlin T. Energy metabolism of human neutrophils during phagocytosis, J Clin Invest. 1982;70:550-557.
48. Roos D, Curnutte JT. Chronic granulomatous disease. In: Ochs HD, Smith CIE, Puck JM, eds. Primary Immunodeficiency Diseases, A Molecular and Genetic Approach. Oxford University Press, New York; 1999:353-374.
49. Papa S, Skulachev VP. Reactive oxygen species, mitochondria, apoptosis and aging. Mol Cell Biochem. 1997;174:305-319.
50. Finkel T. Oxygen radicals and signaling. Curr Opin Cell Biol. 1998;10:248-253.
51. Lenaz G. Role of mitochondria in oxidative stress and ageing. Biochim Biophys Acta. 1998;1366:53-67.
52. Lee HC, Wei YH. Mitochondrial role in life and death of the cell. J Biomed Sci. 2000;7:2-15.
53. Richter C, Gogvadze V, Laffranchi R, et al. Oxidants in mitochondria: from physiology to diseases. Biochim Biophys Acta. 1995;1271:67-74.
54. Davies KJ, Lin SW, Pacifici RE. Protein damage and degradation by oxygen radicals. IV. Degradation of denatured protein. J Biol Chem. 1987;262:9914-9920.
55. Dean RT, Pollak JK. Endogenous free radical generation may influence proteolysis in mitochondria. Biochem Biophys Res Commun. 1985;126:1082-1089.
56. Vercammen D, Beyaert R, Denecker G, et al. Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor. J Exp Med. 1998;187:1477-1485.
57. Costantini P, Bruey JM, Castedo M, et al. Preprocessed caspase-9 contained in mitochondria participates in apoptosis. Cell Death Differ. 2002;9:82-88.
58. Luschen S, Ussat S, Scherer G, Kabelitz D, Adam-Klages S. Sensitization to death receptor cytotoxicity by inhibition of fas-associated death domain protein (FADD)/caspase signaling. Requirement of cell cycle progression. J Biol Chem. 2000;275:24670-24678.
59. Kroemer G, Petit P, Zamzami N, Vayssiere JL, Mignotte B. The biochemistry of programmed cell death. FASEB J. 1995;9:1277-1287.
60. HaunstetterA, Izumo S. Toward antiapoptosis as a new treatment modality. Circ Res. 2000;86:371-376.
61. Nicholson DW. From bench to clinic with apoptosis-based therapeutic agents. Nature. 2000;407:810-816.
62. Cursio R, Gugenheim J, Ricci JE, et aI.A caspase inhibitor fully protects rats against lethal normothermic liver ischemia by inhibition of liver apoptosis. FASEB J. 1999;13:253-261.
63. Daemen MA, van 't Veer C, Denecker G, et al. Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation. J Clin Invest. 1999;104:541-549.
64. Mocanu MM, Baxter GF, Yellen DM. Caspase inhibition and limitation of myocardial infarct size: protection against lethal reperfusion injury. Br J Pharmacol. 2000;130:197-200.
65. Braun JS, Novak R, Herzog KH, Bodner SM, Cleveland JL, Tuomanen El. Neuroprotection by a caspase inhibitor in acute bacterial meningitis. Nat Med. 1999;5:298-302.
66. Grobmyer SR, Armstrong RC, Nicholson SC, et al. Peptidomimetic fluoromethylketone rescues mice from lethal endotoxic shock. Mol Med. 1999;5:585-594.
67. Uzzo RG, Dulin N, Bloom T, Bukowski R, Finke JH, Kolenko V. Inhibition of NFkappaB induces caspase-independent cell death in human T lymphocytes. Biochem Biophys Res Commun. 2001;287:895-899.
68. Sharif-Askari E, Alam A, Rheaume E, et al. Direct cleavage of the human DNA fragmentation factor-45 by granzyme B induces caspase-activated DNase release and DNA fragmentation. EMBO J. 2001;20:3101-3113.
69. Herkert M, Shakhman O, Schweins E, Becker CM. Beta-bungarotoxin is a potent inducer of apoptosis in cultured rat neurons by receptor-mediated internalization. Eur J Neurosci. 2001;14:821-828.
70. Volbracht C, Leist M, Kolb SA, Nicotera P. Apoptosis in caspase-inhibited neurons. Mol Med. 2001;7:36-48.
71. Chechlacz M, Vemuri MC, Naegele JR. Role of DNA-dependent protein kinase in neuronal survival. J Neurochem. 2001;78:141-154.
72. Somervaille TC, Linch DC, Khwaja A. Growth factor withdrawal from primary human erythroid progenitors induces apoptosis through a pathway involving glycogen synthase kinase-3 and Bax. Blood. 2001;98:1374-1381.
73. Miyazaki K, Yoshida H, Sasaki M, et al. Caspase-independent cell death and mitochondrial disruptions observed in the Apafl-deficient cells. J Biochem (Tokyo). 2001;129:963-969.